The phrase "a range of biologic" is not entirely correct in standard written English; it should be "a range of biological." You can use it when discussing various types or categories of biological entities or phenomena.
Example: "The study examined a range of biological responses to the new treatment."
Alternatives: "a variety of biological" or "a spectrum of biological".
The immobilization of an enzyme is one of the crucial factors in a range of biologic techniques.
Chemokines have a range of biologic activities, including regulation of leukocyte trafficking, modulation of hematopoietic cell proliferation, and adhesion to extracellular matrix molecules.
While her own research involves investigating the molecular problems of deafness, she also reviews applications on many topics that include simple and complex genetics, covering a range of biologic systems such as neurologic and mitochondrial diseases.
A range of biologic and epidemiologic evidence documents a key role of the hormonal milieu in the etiology of several cancers, including breast, ovarian, endometrial, prostate, colorectal, lung, and pancreatic cancers.
Occurring along a continuum, symptoms and reversibility vary among diagnosed individuals from mild to severe and are quantifiable by a range of biologic and clinical indicators (NIH 2003).
Adverse interactions between DNA and environmental toxins may be mitigated through a range of biologic defense mechanisms, including DNA repair, cell cycle checkpoint control and xenobiotic clearance enzymes.
Such a methodology would also allow the construction of a range of biologics with dual function, e.g. theranostics, or facilitate the optimal conjugation of both a drug, or imaging probe, with a lifetime extension technology.
The miRNA contains an average of 22 nucleotides and plays important roles in a wide range of biologic processes, such as development, cell growth, cell proliferation, and death [ 23].
Generally, nanoparticles have greater intracellular uptake compared with microparticles and are available to a greater range of biologic targets due to their smaller size and mobility [10].
To evaluate the potentials of infliximab, a mouse human chimeric immunoglobulin G1 monoclonal antibody that binds both the soluble form and the membrane-bound precursor of tumor necrosis factor-α (TNF-α), thus inhibiting a broad range of biologic activities of TNF-α, in the therapy of patients with acute HLA B27 associated anterior uveitis.
